Angray Kang - Search Results

Year	Number of Results
2004	4
2005	1
2006	1
2009	1
2010	3
2011	4
2012	2
2018	1
2019	2
2020	9
2021	6
2022	4
2023	1

1

The impact of sphingosine-1-phosphate receptor modulators on COVID-19 and SARS-CoV-2 vaccination.

Baker D, Forte E, Pryce G, Kang AS, James LK, Giovannoni G, Schmierer K. Baker D, et al. Among authors: kang as. Mult Scler Relat Disord. 2023 Jan;69:104425. doi: 10.1016/j.msard.2022.104425. Epub 2022 Nov 22. Mult Scler Relat Disord. 2023. PMID: 36470168 Free PMC article. Review.

2

Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis.

Tallantyre EC, Scurr MJ, Vickaryous N, Richards A, Anderson V, Baker D, Chance R, Evangelou N, George K, Giovannoni G, Harding KE, Hibbert A, Ingram G, Jolles S, Jones M, Kang AS, Loveless S, Moat SJ, Robertson NP, Rios F, Schmierer K, Willis M, Godkin A, Dobson R. Tallantyre EC, et al. Among authors: kang as. Mult Scler Relat Disord. 2022 Aug;64:103937. doi: 10.1016/j.msard.2022.103937. Epub 2022 Jun 4. Mult Scler Relat Disord. 2022. PMID: 35700625 Free PMC article.

3

Seroconversion following COVID-19 vaccination: Can we optimize protective response in CD20-treated individuals?

Baker D, MacDougall A, Kang AS, Schmierer K, Giovannoni G, Dobson R. Baker D, et al. Among authors: kang as. Clin Exp Immunol. 2021 Nov 18;207(3):263-71. doi: 10.1093/cei/uxab015. Online ahead of print. Clin Exp Immunol. 2021. PMID: 35020857 Free PMC article.

4

CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in multiple sclerosis.

Baker D, MacDougall A, Kang AS, Schmierer K, Giovannoni G, Dobson R. Baker D, et al. Among authors: kang as. Mult Scler Relat Disord. 2022 Jan;57:103448. doi: 10.1016/j.msard.2021.103448. Epub 2021 Dec 4. Mult Scler Relat Disord. 2022. PMID: 34902760 Free PMC article.

5

COVID-19 Vaccine Response in People with Multiple Sclerosis.

Tallantyre EC, Vickaryous N, Anderson V, Asardag AN, Baker D, Bestwick J, Bramhall K, Chance R, Evangelou N, George K, Giovannoni G, Godkin A, Grant L, Harding KE, Hibbert A, Ingram G, Jones M, Kang AS, Loveless S, Moat SJ, Robertson NP, Schmierer K, Scurr MJ, Shah SN, Simmons J, Upcott M, Willis M, Jolles S, Dobson R. Tallantyre EC, et al. Among authors: kang as. Ann Neurol. 2022 Jan;91(1):89-100. doi: 10.1002/ana.26251. Epub 2021 Nov 17. Ann Neurol. 2022. PMID: 34687063 Free PMC article.

6

Anti-drug antibodies to antibody-based therapeutics in multiple sclerosis.

Baker D, Asardag AN, Quinn OA, Efimov A, Kang AS. Baker D, et al. Among authors: kang as. Hum Antibodies. 2021;29(4):255-262. doi: 10.3233/HAB-210453. Hum Antibodies. 2021. PMID: 34397407

7

Immunogenicity of biologics used in the treatment of inflammatory bowel disease.

Bqain M, Efimov A, Baker D, Kang AS. Bqain M, et al. Among authors: kang as. Hum Antibodies. 2021;29(4):225-235. doi: 10.3233/HAB-210449. Hum Antibodies. 2021. PMID: 34151784 Review.

8

Immunogenicity of biologics used in the treatment of moderate to severe psoriasis.

Patel V, Efimov A, Baker D, Kang AS. Patel V, et al. Among authors: kang as. Hum Antibodies. 2021;29(3):171-178. doi: 10.3233/HAB-210447. Hum Antibodies. 2021. PMID: 34151782 Review.

9

New mouthwash: an efficacious intervention for oral ulceration associated with Behçet's disease.

Senusi A, Kang A, Buchanan JAG, Adesanya A, Aloraini G, Stanford M, Fortune F. Senusi A, et al. Among authors: kang a. Br J Oral Maxillofac Surg. 2020 Oct;58(8):1034-1039. doi: 10.1016/j.bjoms.2020.07.027. Epub 2020 Jul 25. Br J Oral Maxillofac Surg. 2020. PMID: 32819746

10

Mapping the T cell response to COVID-19.

Li J, Wang J, Kang AS, Sacitharan PK. Li J, et al. Among authors: kang as. Signal Transduct Target Ther. 2020 Jul 2;5(1):112. doi: 10.1038/s41392-020-00228-1. Signal Transduct Target Ther. 2020. PMID: 32616709 Free PMC article. No abstract available.

11

Detecting and predicting neutralization of alemtuzumab responses in MS.

Saxena G, Moore JM, Jones M, Pryce G, Ali L, Leisegang GR, Vijay V, Loveless S, Robertson NP, Schmierer K, Giovannoni G, Gnananpavan S, Baker D, Tallantyre EC, Kang AS. Saxena G, et al. Among authors: kang as. Neurol Neuroimmunol Neuroinflamm. 2020 Jun 4;7(4):e767. doi: 10.1212/NXI.0000000000000767. Print 2020 Jul. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32499328 Free PMC article.

12

The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic.

Baker D, Amor S, Kang AS, Schmierer K, Giovannoni G. Baker D, et al. Among authors: kang as. Mult Scler Relat Disord. 2020 Aug;43:102174. doi: 10.1016/j.msard.2020.102174. Epub 2020 May 12. Mult Scler Relat Disord. 2020. PMID: 32464584 Free PMC article. Review.

13

Adiponectin exacerbates influenza infection in elderly individuals via IL-18.

Jiang Y, Yi C, Yi Y, Jin Q, Kang AS, Li J, Kumar Sacitharan P. Jiang Y, et al. Among authors: kang as. Signal Transduct Target Ther. 2020 Apr 3;5(1):32. doi: 10.1038/s41392-020-0141-y. Signal Transduct Target Ther. 2020. PMID: 32296048 Free PMC article. No abstract available.

14

The Irony of Humanization: Alemtuzumab, the First, But One of the Most Immunogenic, Humanized Monoclonal Antibodies.

Baker D, Ali L, Saxena G, Pryce G, Jones M, Schmierer K, Giovannoni G, Gnanapavan S, Munger KC, Samkoff L, Goodman A, Kang AS. Baker D, et al. Among authors: kang as. Front Immunol. 2020 Feb 14;11:124. doi: 10.3389/fimmu.2020.00124. eCollection 2020. Front Immunol. 2020. PMID: 32117274 Free PMC article.

15

A cell-based assay for the detection of neutralizing antibodies against alemtuzumab.

Ali L, Saxena G, Jones M, Leisegang GR, Gammon L, Gnanapavan S, Giovannoni G, Schmierer K, Baker D, Kang AS. Ali L, et al. Among authors: kang as. Biotechniques. 2020 Apr;68(4):185-190. doi: 10.2144/btn-2019-0122. Epub 2020 Feb 25. Biotechniques. 2020. PMID: 32096651 Free PMC article.

16

Induction of p53 in keratinocyte cultures treated with Behçet's patient sera.

Houacine S, Kang A, Parkinson EK, Wan H, Fortune F. Houacine S, et al. Among authors: kang a. J Oral Pathol Med. 2020 May;49(5):435-442. doi: 10.1111/jop.13005. Epub 2020 Mar 1. J Oral Pathol Med. 2020. PMID: 32060959

17

GloBody Technology: Detecting Anti-Drug Antibody against VH/VL domains.

Saxena GK, Theocharopoulos I, Aziz NT, Jones M, Gnanapavan S, Giovannoni G, Schmierer K, Garnett JA, Baker D, Kang AS. Saxena GK, et al. Among authors: kang as. Sci Rep. 2020 Feb 5;10(1):1860. doi: 10.1038/s41598-020-58041-3. Sci Rep. 2020. PMID: 32024871 Free PMC article.

18

Evidence for the Desmosomal Cadherin Desmoglein-3 in Regulating YAP and Phospho-YAP in Keratinocyte Responses to Mechanical Forces.

Uttagomol J, Ahmad US, Rehman A, Huang Y, Laly AC, Kang A, Soetaert J, Chance R, Teh MT, Connelly JT, Wan H. Uttagomol J, et al. Among authors: kang a. Int J Mol Sci. 2019 Dec 10;20(24):6221. doi: 10.3390/ijms20246221. Int J Mol Sci. 2019. PMID: 31835537 Free PMC article.

19

The desmosomal cadherin desmoglein-3 acts as a keratinocyte anti-stress protein via suppression of p53.

Rehman A, Cai Y, Hünefeld C, Jedličková H, Huang Y, Teck Teh M, Sharif Ahmad U, Uttagomol J, Wang Y, Kang A, Warnes G, Harwood C, Bergamaschi D, Kenneth Parkinson E, Röcken M, Wan H. Rehman A, et al. Among authors: kang a. Cell Death Dis. 2019 Oct 3;10(10):750. doi: 10.1038/s41419-019-1988-0. Cell Death Dis. 2019. PMID: 31582719 Free PMC article.

20

Alemtuzumab depletion failure can occur in multiple sclerosis.

Dubuisson N, Baker D, Kang AS, Pryce G, Marta M, Visser LH, Hofmann WE, Gnanapavan S, Giovannoni G, Schmierer K. Dubuisson N, et al. Among authors: kang as. Immunology. 2018 Jun;154(2):253-260. doi: 10.1111/imm.12879. Epub 2018 Jan 4. Immunology. 2018. PMID: 29247512 Free PMC article.

21

Accessing of recombinant human monoclonal antibodies from patient libraries by eukaryotic ribosome display.

Tang J, Wang L, Markiv A, Jeffs SA, Dreja H, McKnight Á, He M, Kang AS. Tang J, et al. Among authors: kang as. Hum Antibodies. 2012;21(1-2):1-11. doi: 10.3233/HAB-2011-0257. Hum Antibodies. 2012. PMID: 22885956 Free PMC article.

22

Ribosome display of combinatorial antibody libraries derived from mice immunized with heat-killed Xylella fastidiosa and the selection of MopB-specific single-chain antibodies.

Azizi A, Arora A, Markiv A, Lampe DJ, Miller TA, Kang AS. Azizi A, et al. Among authors: kang as. Appl Environ Microbiol. 2012 Apr;78(8):2638-47. doi: 10.1128/AEM.07807-11. Epub 2012 Feb 10. Appl Environ Microbiol. 2012. PMID: 22327580 Free PMC article.

23

Expression of recombinant multi-coloured fluorescent antibodies in gor -/trxB- E. coli cytoplasm.

Markiv A, Beatson R, Burchell J, Durvasula RV, Kang AS. Markiv A, et al. Among authors: kang as. BMC Biotechnol. 2011 Nov 30;11:117. doi: 10.1186/1472-6750-11-117. BMC Biotechnol. 2011. PMID: 22129156 Free PMC article.

24

Paratransgenic control of vector borne diseases.

Hurwitz I, Fieck A, Read A, Hillesland H, Klein N, Kang A, Durvasula R. Hurwitz I, et al. Among authors: kang a. Int J Biol Sci. 2011;7(9):1334-44. doi: 10.7150/ijbs.7.1334. Epub 2011 Nov 1. Int J Biol Sci. 2011. PMID: 22110385 Free PMC article. Review.

25

Development of transgenic fungi that kill human malaria parasites in mosquitoes.

Fang W, Vega-Rodríguez J, Ghosh AK, Jacobs-Lorena M, Kang A, St Leger RJ. Fang W, et al. Among authors: kang a. Science. 2011 Feb 25;331(6020):1074-7. doi: 10.1126/science.1199115. Science. 2011. PMID: 21350178 Free PMC article.

26

Module based antibody engineering: a novel synthetic REDantibody.

Markiv A, Anani B, Durvasula RV, Kang AS. Markiv A, et al. Among authors: kang as. J Immunol Methods. 2011 Feb 1;364(1-2):40-9. doi: 10.1016/j.jim.2010.10.009. Epub 2010 Nov 3. J Immunol Methods. 2011. PMID: 21055406 Free PMC article.

27

Mosquito-bacteria symbiosis: the case of Anopheles gambiae and Asaia.

Damiani C, Ricci I, Crotti E, Rossi P, Rizzi A, Scuppa P, Capone A, Ulissi U, Epis S, Genchi M, Sagnon N, Faye I, Kang A, Chouaia B, Whitehorn C, Moussa GW, Mandrioli M, Esposito F, Sacchi L, Bandi C, Daffonchio D, Favia G. Damiani C, et al. Among authors: kang a. Microb Ecol. 2010 Oct;60(3):644-54. doi: 10.1007/s00248-010-9704-8. Epub 2010 Jun 23. Microb Ecol. 2010. PMID: 20571792 Free article.

28

Trypanosoma cruzi: synergistic cytotoxicity of multiple amphipathic anti-microbial peptides to T. cruzi and potential bacterial hosts.

Fieck A, Hurwitz I, Kang AS, Durvasula R. Fieck A, et al. Among authors: kang as. Exp Parasitol. 2010 Aug;125(4):342-7. doi: 10.1016/j.exppara.2010.02.016. Epub 2010 Mar 3. Exp Parasitol. 2010. PMID: 20206169 Free PMC article.

29

Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals.

Nguyen TV, Sacci JB Jr, de la Vega P, John CC, James AA, Kang AS. Nguyen TV, et al. Among authors: kang as. Malar J. 2009 Oct 23;8:235. doi: 10.1186/1475-2875-8-235. Malar J. 2009. PMID: 19852802 Free PMC article.

30

Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthrax.

Peterson JW, Comer JE, Noffsinger DM, Wenglikowski A, Walberg KG, Chatuev BM, Chopra AK, Stanberry LR, Kang AS, Scholz WW, Sircar J. Peterson JW, et al. Among authors: kang as. Infect Immun. 2006 Feb;74(2):1016-24. doi: 10.1128/IAI.74.2.1016-1024.2006. Infect Immun. 2006. PMID: 16428748 Free PMC article.

31

Cognate peptide-receptor ligand mapping by directed phage display.

Stratmann T, Kang AS. Stratmann T, et al. Among authors: kang as. Proteome Sci. 2005 Jun 17;3:7. doi: 10.1186/1477-5956-3-7. Proteome Sci. 2005. PMID: 15963231 Free PMC article.

32

Human monoclonal antibodies that neutralize anthrax toxin by inhibiting heptamer assembly.

Wang F, Ruther P, Jiang I, Sawada-Hirai R, Sun SM, Nedellec R, Morrow PR, Kang AS. Wang F, et al. Among authors: kang as. Hum Antibodies. 2004;13(4):105-10. Hum Antibodies. 2004. PMID: 15671576

33

IgG(4) Pf NPNA-1 a human anti-Plasmodium falciparum sporozoite monoclonal antibody cloned from a protected individual inhibits parasite invasion of hepatocytes.

Chappel JA, Hollingdale MR, Kang AS. Chappel JA, et al. Among authors: kang as. Hum Antibodies. 2004;13(3):91-6. Hum Antibodies. 2004. PMID: 15598989

34

Molecular dissection of the human antibody response to the structural repeat epitope of Plasmodium falciparum sporozoite from a protected donor.

Chappel JA, Rogers WO, Hoffman SL, Kang AS. Chappel JA, et al. Among authors: kang as. Malar J. 2004 Jul 29;3:28. doi: 10.1186/1475-2875-3-28. Malar J. 2004. PMID: 15283866 Free PMC article.

35

Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed.

Sawada-Hirai R, Jiang I, Wang F, Sun SM, Nedellec R, Ruther P, Alvarez A, Millis D, Morrow PR, Kang AS. Sawada-Hirai R, et al. Among authors: kang as. J Immune Based Ther Vaccines. 2004 May 12;2(1):5. doi: 10.1186/1476-8518-2-5. J Immune Based Ther Vaccines. 2004. PMID: 15140257 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results